Allogene Therapeutics, Inc.(ALLO:US)

Market Cap$320.71M

Key Metrics

Price$1.31

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$173.76M

EBITDA (TTM)-$158.02M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$30.31M

Total Assets$395.96M

Net Assets$278.88M

Total Debt$72.63M

Allogene Therapeutics, Inc.(ALLO:US)

Market Cap$320.71M

Price history

Key Metrics

Price$1.31

Revenue (TTM)$0

Holders Revenue (TTM)-

Gross Profit (TTM)-

Earnings (TTM)-$173.76M

EBITDA (TTM)-$158.02M

Op. Margin (TTM)-

Dividend Yield-

Holders Yield-

Cash on hand$30.31M

Total Assets$395.96M

Net Assets$278.88M

Total Debt$72.63M

Financials

NameMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Revenue
$0$0$0$0$0$0$0$0$22K-$44K$22K$22K$30K$47K$49K$86K$61K$51K$49K$44K$38.35M$0$0$0$0$0$0$0$0$0$0$0$0-
Cost of Revenue
----------------------------------
Gross Profit
----------------------------------
$46.09M$42.4M$44.9M$54.44M$65.19M$60.49M$61.05M$66.44M$69.53M$71.89M$63.02M$80.56M$99.12M$96.42M$82.54M$76.68M$80.05M$73.94M$77.72M$71.07M$71.55M$69.36M$68.04M$63.16M$57.68M$64.58M$55.01M$45.96M$36.46M$33.05M$22.19M$135.01M$2.6M$2K
Research and Development$32M$28.63M$31.16M$40.16M$50.2M$44.97M$44.71M$50.36M$52.26M$54.66M$45.98M$62.04M$80.24M$75.42M$63.64M$57.17M$60.16M$53.98M$58.72M$52.29M$55.18M$52.23M$51.42M$47.3M$42.04M$49.36M$40M$31.77M$23.4M$18.5M$10.87M$122.49M$0$0
Selling, General, and Administrative$14.09M$13.77M$13.74M$14.28M$14.99M$15.52M$16.33M$16.09M$17.27M$17.22M$17.04M$18.52M$18.88M$21M$18.9M$19.51M$19.9M$19.96M$19M$18.78M$16.36M$17.13M$16.62M$15.86M$15.64M$15.21M$15.02M$14.19M$13.06M$14.54M$11.32M$12.53M$2.6M$2K
Other Operating Expenses----------------------------------
Operating Income
-$46.09M-$42.4M-$44.9M-$54.44M-$65.19M-$60.49M-$61.05M-$66.44M-$69.5M-$71.93M-$63M-$80.54M-$99.09M-$96.37M-$82.49M-$76.59M-$79.99M-$73.89M-$77.67M-$71.03M-$33.2M-$69.36M-$68.04M-$63.16M-$57.68M-$64.58M-$55.01M-$45.96M-$36.46M-$33.05M-$22.19M-$135.01M-$2.6M-$2K
$3.49M$3.59M$3.5M$3.49M$5.46M$994K-$5.25M$84K$4.5M-$17.33M$709K$1.31M-$876K$1.53M-$659K$1.81M$142K-$975K-$516K$93K$186K$792K$1.84M$2.18M$3.2M$3.66M$4.31M$4.56M$4.83M$2.42M-$21.31M$110K$0$0
Non-Operating Interest Income$3.57M$3.66M$3.93M$6.19M$5.52M$3.03M$6.71M$4.99M$5.43M$6.27M$6.21M$3.78M$2.06M$2.76M$1M$315K$492K$186K$393K$624K$511K$1.56M$2.01M$2.34M$3.26M$3.66M$4.31M$4.56M$4.83M$4.22M$1.46M$110K$0$0
Non-Operating Interest Expense$300K$313K$344K$268K$150K$81K$100K---$0--------------$0$0--$0$3.36M---
Other Income/Expense$212K$247K-$81K-$2.43M$92K-$1.95M-$11.85M-$4.9M-$929K-$23.59M-$5.5M-$2.47M-$2.94M-$1.23M-$1.66M$1.49M-$350K-$1.16M-$909K-$531K-$325K-$766K-$162K-$156K-$58K-----$1.8M-$19.42M---
Income Before Tax
-$42.61M-$38.81M-$41.4M-$50.94M-$59.73M-$59.5M-$66.29M-$66.36M-$65M-$89.26M-$62.29M-$79.23M-$99.97M-$94.85M-$83.15M-$74.79M-$79.85M-$74.87M-$78.19M-$70.94M-$33.02M-$68.57M-$66.2M-$60.97M-$54.48M-$61.19M-$50.7M-$41.4M-$31.64M-$30.63M-$43.5M-$134.9M-$2.6M-$2K
Income Tax
---------------------$0$0$0$0-$155K$33K-$159K-$50K-$0$0$0-
Net Income
-$42.61M-$38.81M-$41.4M-$50.94M-$59.73M-$59.94M-$66.29M-$66.36M-$65M-$89.26M-$62.29M-$79.23M-$99.97M-$94.85M-$83.15M-$74.79M-$79.85M-$74.87M-$78.19M-$70.94M-$33.02M-$68.57M-$66.2M-$60.97M-$54.48M-$61.03M-$50.74M-$41.24M-$31.59M-$30.51M-$43.5M-$134.9M-$2.6M-$2K
Minority Interests
----------------------------------
Preferred Stock Dividends
----------------------------------
Net Income to Common
-$42.61M-$38.81M-$41.4M-$50.94M-$59.73M-$59.94M-$66.29M-$66.36M-$65M-$89.26M-$62.29M-$79.23M-$99.97M-$94.85M-$83.15M-$74.79M-$79.85M-$74.87M-$78.19M-$70.94M-$33.02M-$68.57M-$66.2M-$60.97M-$54.48M-$61.03M-$50.74M-$41.24M-$31.59M-$30.51M-$43.5M-$134.9M-$2.6M-$2K
Shares Outstanding (Basic)
240.29M226.03M222.04M218.93M215.36M210.57M209.19M190.03M169.13M-167.65M146.8M144.56M144.15M143.66M143.39M141.36M139.17M137.03M134.83M132.17M129.84M127.14M115.38M108.96M104.8M102.19M99.85M97.32M82.06M113.69M113.69M44.01M44.01M
Shares Outstanding (Diluted)
240.29M226.03M222.04M218.93M215.36M210.57M209.19M190.03M169.13M-167.65M146.8M144.56M144.15M143.66M143.39M141.36M139.17M137.03M134.83M132.17M129.84M127.14M115.38M108.96M104.8M102.19M99.85M97.32M82.06M113.69M113.69M44.01M44.01M
EPS (Basic)
-$0.18-$0.17-$0.19-$0.23-$0.28-$0.28-$0.32-$0.35-$0.38--$0.37-$0.54-$0.69-$0.66-$0.58-$0.52-$0.56-$0.54-$0.57-$0.53-$0.25-$0.53-$0.52-$0.53-$0.50-$0.58-$0.50-$0.41-$0.32-$0.37-$0.38-$1.19-$0.059-$0.000045
EPS (Diluted)
-$0.18-$0.17-$0.19-$0.23-$0.28-$0.28-$0.32-$0.35-$0.38--$0.37-$0.54-$0.69-$0.66-$0.58-$0.52-$0.56-$0.54-$0.57-$0.53-$0.25-$0.53-$0.52-$0.53-$0.50-$0.58-$0.50-$0.41-$0.32-$0.37-$0.38-$1.19-$0.059-$0.000045
EBIT
-$42.31M-$38.5M-$41.06M-$50.68M-$59.58M-$59.42M-$66.19M-$66.44M-$69.5M-$71.93M-$62.29M-$80.54M-$99.09M-$96.37M-$82.49M-$76.59M-$79.99M-$73.89M-$77.67M-$71.03M-$33.2M-$61.34M-$68.04M-$63.16M-$57.68M-$61.19M-$55.01M-$45.96M-$36.46M-$30.63M-$40.14M-$135.01M-$2.6M-$2K
EBITDA
-$39.44M-$35.44M-$37.96M-$45.19M-$56.48M-$56.18M-$52.26M-$57.81M-$65.95M-$68.45M-$58.72M-$76.9M-$95.59M-$93.31M-$78.63M-$72.92M-$76.3M-$69.65M-$75.34M-$69.07M-$31.28M-$59.5M-$66.23M-$61.27M-$55.64M-$59.33M-$53.68M-$44.81M-$35.77M-$30.08M-$39.64M-$134.56M-$2.6M-$2K